Wraight, E P <br/><br/>
The use of a chelating derivative of alpha melanocyte stimulating hormone for the clinical imaging of malignant melanoma.  [electronic resource] 

 -  The British journal of radiology  Feb 1992 
 - 112-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1285 
<br/><br/><label>Standard No.: </label>10.1259/0007-1285-65-770-112  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Chelating Agents<br/>Drug Evaluation<br/>Female<br/>Humans<br/>Indium Radioisotopes<br/>Lung Neoplasms--diagnostic imaging<br/>Lymphatic Metastasis<br/>Male<br/>Melanocyte-Stimulating Hormones<br/>Melanoma--diagnostic imaging<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Palatal Neoplasms--diagnostic imaging<br/>Pentetic Acid<br/>Radionuclide Imaging<br/>Spinal Neoplasms--diagnostic imaging